High dose adenosine in acute myocardial infarction study
- Conditions
- Patients with acute myocardial infarction treated by primary PCI
- Registration Number
- NL-OMON23567
- Lead Sponsor
- none
- Brief Summary
Stoel MG, Marques KM, de Cock CC, Bronzwaer JG, von Birgelen C, Zijlstra F. <br><br> High dose adenosine for suboptimal myocardial reperfusion after primary PCI: A randomized placebo-controlled pilot study. Catheter Cardiovasc Interv. 2008 Feb 15;71(3):283-9.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 80
Inclusion Criteria
1. Acute myocardial infarction (typical chest pain for at least 30 minutes and less then 12 hours, and > 1 mm ST-segment elevation in > 2 leads) for which primary PCI is performed.
Exclusion Criteria
1. Haemodynamic instability
2. Severe COPD
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Area of 'no reflow' and final infarct area determined by 3 month MRI
- Secondary Outcome Measures
Name Time Method eft Ventricle function, ST-segment resolution, enzyme release, angiographic parameters (MBG, TFC), clinical end points